Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass

✍ Scribed by P. Hadji; D. Gamerdinger; W. Spieler; P. H. Kann; H. Loeffler; K. Articus; R. Möricke; V. Ziller

• Publisher: Springer-Verlag
• Year: 2011
• Tongue: English
• Weight: 228 KB
• Volume: 23
• Category: Article
• ISSN: 0937-941X
• DOI: 10.1007/s00198-011-1583-4